Enveric Biosciences, Inc.

Analysis for Ticker: ENVB

Enveric Biosciences Inc says it is a biology company developing new brain drugs like the EB-003 and EVM401 series to help people with depression and anxiety without making them hallucinate. The financial reality is a disaster because the company makes exactly 0,00$ in revenue while spending millions of dollars on executive salaries and banking fees. An investment of 100,00$ at the end of 2022 was reduced to just 0,97$ by the end of 2025. This happened because the company works like a printing press that makes new pieces of paper called stock to pay its bills, but every time they print more, the pieces of paper you already own become worth much less. By the end of 2025, they had already lost a total of 114,8$ million since they began.